Total synthesis of photoactivatable or fluorescent anandamide probes: Novel bioactive compounds with angiogenic activity

Journal of Medicinal Chemistry

Volumn 52, Issue 4, 2009, Pages 1005-1017

  Balas, Laurence ^a   Durand, Thierry ^a   Saha, Sattyabrata ^b   Johnson, Inneke ^b   Mukhopadhyay, Somnath ^b  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,10,13,16 DOCOSATETRAENOYLETHANOLAMIDE; ANANDAMIDE; CANNABINOID RECEPTOR; COPPER; HOMO GAMA LINOLENOYLETHANOLAMIDE; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG; VIRODHAMINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL REACTION; CROSS COUPLING REACTION; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM CELL; HYDROGENATION; IN VITRO STUDY; IRRADIATION; MOUSE; NONHUMAN; PHOTOACTIVATION; PHOTOAFFINITY LABELING; UMBILICAL VEIN;

ARACHIDONIC ACIDS; AZIDES; AZIRINES; CELLS, CULTURED; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; HUMANS; MATRIX METALLOPROTEINASES; MOLECULAR PROBES; NEOVASCULARIZATION, PHYSIOLOGIC; PHOTOAFFINITY LABELS; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB2;

EID: 64349118888     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm8011382     Document Type: Article

References (63)

1. Hanus, L. O. Discovery and isolation of anandamide and other endocannabinoids. Chem. Biodiversity 2007, 4, 1828-1841.
2. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
3. (a) Burstein, S. H.; Adams, J. K.; Bradshaw, H. B.; Fraioli, C.; Rossetti, R. G.; Salmonsen, R. A.; Shaw, J. W.; Walker, J. M.; Zipkin, R. E.; Zurier, R. B. Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg. Med. Chem. 2007, 15, 3345-3355.
4. (b) Burstein, S. The elmiric acids: biologically active anandamide analogs. Neuropharmacology 2007, doi:10.1016/j.neuropharm.2007.11. 011.
5. Kogan, N. M.; Mechoulam, R. J. The chemistry of endocannabinoids. Endocrinol. Invest. 2006, 29, 3-14.
6. Milman, G.; Maor, Y.; Abu-Lafi, S.; Horowitz, M.; Gallily, R.; Batkai, S.; Mo, F. M.; Offertaler, L.; Pacher, P.; Kunos, G.; Mechoulam, R. N-Arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 2428-2433.
7. Saghatelian, A.; McKinney, M. K.; Bandell, M.; Patapoutian, A.; Cravatt, B. F. A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 2006, 45, 9007-9015.
8. Mechoulam, R. Cannabinoids as Therapeutics; Mechoulam, R., Ed.; Milestones in Drug Therapy; Birkhauser Publisher: Basel, Switzerland, 2005.
9. Grimaldi, C.; Bibulco, M. Anandamide, an endogenous ligand of cannabinoids receptors, inhibits human breast cancer cell proliferation through a lipid rafts mediated mechanism. Pharmacologyonline 2007, 1, 1-45.
10. Di Marzo, V.; Petrosino, S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 2007, 18, 129-140.
11. Howlett, A. C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.; Herkenham, M.; Mackie, K.; Martin, B. R.; Mechoulam, R.; Pertwee, R. G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev 2002, 54, 161-202.
12. (a) Steffens, M.; Zentner, J.; Honegger, J.; Feuerstein, T. J. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor. Biochem. Pharmacol. 2005, 69, 169-178.
13. (b) Porter, A. C.; Sauer, J. M.; Knierman, M. D.; Becker, G. W.; Berna, M. J.; Bao, J.; Nomikos, G. G.; Carter, P.; Bymaster, F. P.; Leese, A. B.; Felder, C. C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 2002, 301, 1020-1024.
14. Fride, E.; Gobshtis, N. Endocannabinoids and their receptors: physiology, pathology and pharmacology. Immunol., Endocr. Metab. Agents Med. Chem. 2007, 7, 157-173.
15. A full issue of the British Journal of Pharmacology (2008, 153 (2)) is dedicated to reviews and topics on the CB2 receptor, stemming from a meeting "CB2 Receptors: New Vistas" that was held in Canada in June 2007.
16. (a) Liu, J.; Wang, L.; Harvey-White, J.; Huang, B. X.; Kim, H. Y.; Luquet, S.; Palmiter, R. D.; Krystal, G.; Rai, R.; Mahadevan, A.; Razdan, R. K.; Kunos, G. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 2008, 54, 1-7.
17. (b) McPartland, J. M.; Norris, R. W.; Kilpatrick, C. W. Coevolution between cannabinoid receptors and endocannabinoid ligands. Gene 2007, 397, 126-135.
18. Demuth, D. G.; Molleman, A. Cannabinoid signalling. Life Sci. 2006, 78, 549-563.
19. Felder, C. C.; Dickason-Chesterfield, A. K.; Moore, S. A. Cannabinoids biology: the search for new therapeutic targets. Mol. Interventions 2006, 6, 149-161.
20. Smita, K.; Sushil Kumar, V.; Premendran, J. S. Anandamide: an update. Fundam. Clin. Pharmacol. 2007, 21, 1-8.
21. Alexander, S. P.; Kendall, D. A. The complications of promiscuity: endocannabinoid action and metabolism. Br. J. Pharmacol. 2007, 152, 602-623.
22. Fowler, C. J. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br. J. Pharmacol. 2007, 152, 594-601.
23. Brown, A. J. Novel cannabinoid receptors. Br. J. Pharmacol. 2007, 152, 567-575.
24. Di Marzo, V.; De Petrocellis, L. Non-CB1 Non CB2 Receptors for Endocannabinoids. In Endocannabinoids: The Brain and Body's Marijuana and Beyond; Onaivi, E. S., Sugiura, T., Di Marzo, V., Eds.; Taylor & Francis: Boca Raton, FL, 2006; Vol. 15, pp 1-174.
25. Begg, M.; Pacher, P.; Batkai, S.; Osei-Hyiaman, D.; Offertaler, L.; Mo, F. M.; Liu, J.; Kunos, G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 2005, 106, 133-145.
26. Pertwee, R. G. Novel pharmacological targets for cannabinoids. Curr. Neuropharmacol. 2004, 2, 9-29.
27. Fride, E.; Foox, A.; Rosenberg, E.; Faigenboim, M.; Cohen, V.; Barda, L.; Blau, H.; Mechoulam, R. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Eur. J. Pharmacol. 2003, 461, 27-34.
28. Di Marzo, V.; De Petrocellis, L.; Fezza, F.; Ligresti, A.; Bisogno, T. Anandamide receptors. Prostaglandins, Leukotrienes Essent. Fatty Acids 2002, 66, 377-391.
29. Perry, S. N.; Johnson, I. J.; Mukhopadhyay, S. Anandamide Mediated Angiogenesis: Interplay between CB1 Receptor and Non CB1/CB2 Anandamide Receptor. Proceedings ofthe 16th Annual Symposium ofCannabinoids, Burlington, VT, 2006; International Cannabinoid Research Society, 2006; p 61.
30. Hilderbrandt, S.; Johnson, I. J.; Mukhopadhyay, S. CB1 Receptor and Non-CB1/CB2 Annadmaide Receptor Mediated Differential S-Ni- trosylation of MMP: A Novel Angiogenic Switch for the Regulation of Angiogenesis (2008). Proceedings of the 18th Annual Symposium of Cannbinoids, Burlington, VT, 2008; International Cannabinoid Research Society, 2008; p 17.
31. McCollum, L.; Howlett; Mukhopadhyay, S. Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J. Pharmacol. Exp. Ther. 2007, 321, 930-937.
32. Daly, C. J.; McGrath, J. C. Fluorescent ligands, antibodies, and proteins for the study of receptors. Pharmacol. Ther. 2003, 100, 101-118.
33. Vodovozova, E. L. Photoaffinity labeling and its application in structural biology. Biochemistry (Moscow) 2007, 72, 1-20.
34. (a) Brase, S.; Gil, C.; Knepper, K.; Zimmermann, V. Organic azides: an exploding diversity of a unique class of compounds. Angew. Chem., Int. Ed. 2005, 44, 5188-240.
35. (b) Bucher, G. Photochemical Reactivity of Azides. In CRC Handbook of Organic Photochemistry and Photobiology, 2nd ed.; Horspool, W. M., Lenci, F., Eds.; CRC Press:Boca Raton, FL, 2004; Chapter 44.
36. (c) Blencowe, A.; Hayes, W. Development and application of diazirines in biological and synthetic macromolecular systems. Soft Matter 2005, 1, 178-205.
37. (d) Sadakane, Y.; Hatanaka, Y. Photochemical fishing approaches for identifying target proteins and elucidating the structure of a ligand-binding region using carbene-generating photoreactive probes. Anal. Sci. 2006, 22, 209-218.
38. (a) Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L. A.; Pertwee, R. G.; Makriyannis, A. (R)-Methanandamide: a chiral novel ananda- mide possessing higher potency and metabolic stability. J. Med. Chem. 1994, 37, 1889-1893.
39. (b) Haller, V. L.; Cichewicz, D. L.; Welch, S. P. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Eur. J. Pharmacol. 2006, 546, 60-68.
40. It must be realized that we are not looking for a specific ligand for CB1 or CB2 receptors but for a mimic of eCBs, mainly anandamide, to search for novel putative receptors. However, very little is known about these targeted new receptors. It is therefore rather difficult to anticipate what structural requirements would be needed for a synthetic ligand.
41. Balas, L.; Cascio, M. G.; Di Marzo, V.; Durand, T. Synthesis of a potential photoactivatable anandamide analog. Bioorg. Med. Chem. Lett. 2006, 16, 3765-3768.
42. Altundas, R.; Mahadevan, A.; Razdan, R. K. A synthetic route to anandamide analogues carrying a substituent at the terminal carbon and an acetylene group in the end pentyl chain. Tetrahedron Lett. 2004, 45, 5449-5451.
43. Li, C.; Xu, W.; Vadivel, S. K.; Fan, P.; Makriyannis, A. High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. J. Med. Chem. 2005, 48, 6423-6429.
44. Dasse, O.; Mahadevan, A.; Han, L.; Martin, B. R.; Marzo, V. D.; Razdan, R. K. The synthesis of N-vanillyl-arachidonoyl-amide (arvanil) and its analogs: an improved procedure for the synthesis of the key synthon methyl 14-hydroxy-(all-cis)-5.8.11-tetradecatrienoate. Tetrahedron 2000, 56, 9195-9202.
45. 3 promoted coupling reactions for the preparation of skipped diynes. Tetrahedron 2003, 59, 7787-7790.
46. Leonard, N. J.; Neelima. 1,1,1,3,3,3-Hexafluoro-2-propanol for the removal of the 4,4′-dimethoxytrityl protecting group from the 5′- hydroxyl of acid-sensitive nucleosides and nucleotides. Tetrahedron Lett. 1995, 36, 7833-7336.
47. Bailey, W. J.; Fujiwara, E. Acetylenes. I. Mixed dihalides and halohydrins from butynediol. J. Am. Chem. Soc. 1955, 1, 165-166.
48. f (hampered by the presence of amine and boron and/or nickel derivatives salts in the ethanolic reaction mixture). Thus, unfortunately, development and completion of the hydrogenation reaction could not be monitored by hydrogen volume absorption measurement or TLC. We had to use a trial and error approach to find the level of poisoning of the catalyst and reaction time.
49. Taber, D. F.; Zhang, Z. J. A linpchin approach to unsaturatted fatty acids 11,12-epoxyeicosatrienoic acid and 11S,12S-dihydroxyeicosa-trienoic acid ethyl esters. Org. Chem. 2005, 70, 8093-8095.
50. (a) Colonge, J.; Poilane, G. Utilisation du chloro-4 butène-2 ol-1 en synthèse organiqueaction sur les composé organomanesiens. Bull. Soc. Chim. Fr. 1955, 953, 955.
51. (b) Imai, T.; Nishida, S. A mild and convenient Barbier-type allylation od aldehyddes to homoallylic alcohol via iodide ion promoted stannylation of allylic bromides and chlorides with tin(II) chloride. Synthesis 1993, 4, 395-399.
52. We were mostly preoccupied with double selectivity versus monose- lectivity on the dichloride 22.
53. Hansen, T. V.; Stenstrom, Y. First total synthesis of (-)-aplyolide A. Tetrahedron: Asymmetry 2001, 12, 1407-1417.
54. (a) Kwok, P.-Y.; Muellner, F. W.; Chen, C.-K.; Fried, J. Total synthesis of 7,7-, 10,10-, and 13,13-difluoroarachidonic acids. J. Am. Chem. Soc. 1987, 109, 3684-3692.
55. (b) Smith, L. M.; Smith, R. G.; Loehr, T. M.; Daves, G. D. Douglas Fir Tusock Moth pheromone: identification of a diene analogue of the principal attractant and synthesis of stereochemically defined 1,6-, 2,6- and 3,6-heneicosadien-11-ones. J. Org. Chem. 1978, 43, 2361-2366.
56. Blackburn, C.; Neumeyer, J. L. Receptor-selective fluorescent probes for use in neuroscience. Med. Chem. Res. 1992, 2, 257-275.
57. Dohi, H.; Nishida, Y.; Mizuno, M.; Shinkai, M.; Kobayashi, T.; Takeda, T.; Uzawa, H.; Kobayashi, K. Synthesis of an artificial glycoconjugate polymer carrying Pk antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin. Bioorg. Med. Chem. 1999, 7, 2053-2062.
58. Perrier, H.; Prasit, P.; Wang, Z. Synthesis of a radioactive photoaffinity arachidonic acid analog. Tetrahedron Lett. 1994, 35, 1501-1502.
59. (a) Church, R. F. R.; Conn, R.; Weiss, M. J. Substituted Diaziridines and Diazirines. U.S. Patent 3,525,736 1970; American Cyanamid Compagny.
60. (b) Church, R. F. R.; Weiss, M. J. Diazirines. II. Synthesis and properties of small functionalized diazirine molecules. Some observations on the reaction of a diaziridine with the iodine- iodide ion system. J. Org. Chem. 1970, 35 (8), 2465-2471.
61. These experiments were run by Pr. Vincenzo DiMarzo team (Napoli) with the same conditions as the ones reported in our preliminary paper (see ref 34).
62. Grant, D. S.; Kinsella, J. L.; Fridman, R.; Auerbach, R.; Piasecki, B. A.; Yamada, Y.; Zain, M.; Kleinman, H. K. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cell Physiol. 1992, 153, 614-625.
63. Koch, A. E.; Halloran, M. M.; Haskell, C. J.; Shah; Polverini. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesionmolecule-1. Nature 1995, 376, 517-519.